NKTR — NEKTAR THERAPEUTICS
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 906709 ·
Last close
$70.67
Market Cap
$2.39B
52W High
$88.10
52W Low
$54.13
ADV30
1,102,183
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 10,861,000 | — | -38,258,000 | -44,904,000 | 763,271,000 | 149,578,000 | 187,055,000 |
| Dec 2025 | 21,807,000 | 21,807,000 | -19,090,000 | -36,079,000 | 280,406,000 | 15,116,000 | 190,574,000 |
| Sep 2025 | 11,790,000 | 11,790,000 | -31,532,000 | -35,522,000 | 301,347,000 | 41,032,000 | 216,261,000 |
| Jun 2025 | 11,175,000 | 11,175,000 | -35,783,000 | -41,593,000 | 207,534,000 | 42,988,000 | 231,745,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-208,511,000
Investing CF
$-1,197,000
Financing CF
$180,566,000
CapEx
$-171,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-10.20
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-3,760,286,000
Inventory
—
Receivables
$1,779,000
ST Investments
$230,636,000
EBIT TTM
$-129,303,000
Pretax Income TTM
$-155,487,000
Interest Exp TTM
$26,184,000
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$55,633,000
EBITDA
$-123,912,000
Free Cash Flow
$-107,228,376
Enterprise Value
$1,962,486,912
Total Cash
$568,604,032
Total Debt
$143,432,000
Shares Out
33,786,032
Trailing EPS
$-7.93
Book Value
$19.55
ROE
-53.6%
ROA
-15.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 55,232,000 | -130,771,000 | -164,076,000 | 280,406,000 | 190,574,000 | — | -208,511,000 |
| Dec 2024 | 98,427,000 | -129,918,000 | -118,961,000 | 303,850,000 | 243,113,000 | — | -175,709,000 |
| Dec 2023 | 90,122,000 | -135,225,000 | -276,056,000 | 398,033,000 | 267,046,000 | — | -192,606,000 |
| Dec 2022 | 92,055,000 | -240,236,000 | -368,198,000 | 710,600,000 | 343,962,000 | — | -304,007,000 |
TTM Snapshot
Revenues TTM
$105,757,000
NetIncome TTM
$-495,945,000
OpCashFlow TTM
$0
Assets (Latest)
$710,600,000
Forward EPS
$-11.87
Max Pain — expiry 2026-08-21
max pain strike: $65.00 · spot: $70.67 · call oi: 9,069 · put oi: 5,329
Expected Move to 2026-08-21:
±$8.70
(12.31%) —
implied range
$61.97 –
$79.37
· ATM straddle on $70.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PBH | Prestige Consumer Healthcare Inc. | $2.38B | $50.22 | — |
| NRIX | Nurix Therapeutics, Inc. | $2.41B | $23.21 | — |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.45B | $24.91 | — |
| VERA | Vera Therapeutics, Inc. | $2.30B | $32.10 | — |
| GIFOF | Grifols SA | $2.29B | $8.85 | — |
News headlines (Yahoo Finance, 1h cache)
Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financial Markets
2026-07-28 22:00 · Yahoo
Does Nektar (NKTR) Have the Potential to Rally 104.06% as Wall Street Analysts Expect?
2026-07-28 13:55 · Yahoo
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-24 20:15 · Yahoo
Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis
2026-07-21 11:00 · Yahoo
NKTR Stock Clocks Best Day In Over 2 Months As Investors Await Upcoming Clinical Data In Eczema
2026-07-03 00:41 · Yahoo
What a $1.2 Million Insider Sale Means for Nektar With Shares Up 160% This Past Year
2026-06-24 19:59 · Yahoo
3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal
2026-06-23 11:55 · Yahoo
A Look At Nektar Therapeutics (NKTR) Valuation After Recent Share Price Volatility
2026-06-07 03:10 · Yahoo
What Makes Nektar Therapeutics (NKTR) a Promising Mid-Cap Healthcare Stock
2026-06-05 15:55 · Yahoo
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
2026-05-27 22:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.